RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023

Rhea-AI Summary

RxSight, Inc. (NASDAQ: RXST) announced that it will report its first quarter 2023 financial results on May 9, 2023, after market close. Management is set to discuss the results during a conference call beginning at 1:30 PM PT / 4:30 PM ET. This call aims to provide insights into the company’s financial performance and future outlook following their innovative advancements in ophthalmic medical devices, specifically their Light Adjustable Lens system designed for cataract surgery. The technology is unique as it allows for post-surgery adjustments to optimize patients' vision quality. Interested investors can register for the call and access it via a live and archived webcast.

Positive

• Upcoming financial results presentation may provide insights into growth.
• Innovative Light Adjustable Lens system allows for customized vision correction post-surgery, potentially leading to increased sales.

Negative

• None.

ALISO VIEJO, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the first quarter 2023 after the market close on Tuesday, May 9, 2023. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Participants may register for the call here and listen through a live and archived webcast of the event available for one year at https://investors.rxsight.com/. While not required, it is recommended that participants join ten minutes prior to the event start time to ensure the necessary audio applications are downloaded and installed. Instructions are provided (including a dial-in option).

About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight^® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens^® (LAL^®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery enabling doctors to customize and deliver high-quality of vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
ir@rxsight.com

FAQ

When will RxSight report its Q1 2023 financial results?

RxSight will report its Q1 2023 financial results on May 9, 2023, after the market closes.

What time is the RxSight Q1 2023 earnings call?

The Q1 2023 earnings call for RxSight will start at 1:30 PM Pacific Time / 4:30 PM Eastern Time.

How can I listen to the RxSight earnings call?

You can listen to the RxSight earnings call through a live and archived webcast available for one year on their investor relations website.

What is the Light Adjustable Lens system by RxSight?

The Light Adjustable Lens system is an innovative intraocular lens technology that can be adjusted after cataract surgery to improve patient vision.